XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 16 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,256,000 | – | 3,240,000 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 7,450,000 | $13,103,000 | 0.84% |
| 683 Capital Management, LLC | 8,100,000 | $14,094,000 | 0.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,000,000 | $31,658,000 | 0.63% |
| Saltoro Capital, LP | 250,000 | $439,000 | 0.22% |
| UBS OCONNOR LLC | 2,000,000 | $3,461,000,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 7,875,000 | $13,836,000 | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4,000,000 | $6,948,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |